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Results and Discussion {#sec1}
======================

The product of the *myo2*-E1 allele is predicted to harbor a substitution of glycine at position 345 with arginine ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). Cells carrying this mutant allele are capable of colony formation at 24°C but are severely compromised for colony formation at 36°C ([Figure 1](#fig1){ref-type="fig"}A) due to defective actomyosin ring assembly \[[@bib6], [@bib7], [@bib9], [@bib10]\]. The *myo2*-E1 mutation resides between α-helix HL and β sheet S1D, which is part of the upper 50 kDa sub-domain in the head of Myo2p ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Previous work has shown that *Myo2*-E1p (product of myo2-E1) does not bind or move actin filaments and has a very low ATPase activity in vitro \[[@bib10], [@bib11]\]. The presence of a bulky arginine side chain between helices HL and HO in the upper 50 kDa sub-domain of this mutant might introduce constraints to the conformational changes in the Myo2p head domain during the actomyosin cycle, resulting in the observed phenotypes. To further understand the role of Myo2p in cytokinesis, we isolated genetic suppressors that restored the ability of *myo2*-E1 cells to form colonies at 36°C ([Figure 1](#fig1){ref-type="fig"}A). One suppressor, *myo2*-E1-Sup1, is described in this study. Genetic crosses between *myo2*-E1-Sup1 and wild-type cells only produced progeny that were able to form colonies at 36°C, suggesting that the suppressor mutation was intragenic or very tightly linked to *myo2*. Nucleotide sequence determination revealed that *myo2*-E1-Sup1 contained the original G345R mutation and also had additional mutations (Q640H and F641I) ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). Furthermore, no sequence alterations were found in the neighboring *rgf3* gene (data not shown), which has also been implicated in cytokinesis \[[@bib12], [@bib13]\]. Therefore, we concluded that the sequence alteration Q640H F641I was responsible for the suppression of *myo2*-E1. Interestingly, Q640H and F641I are located in the HW region of the Myo2p head (within the lower 50 KDa sub-domain), which is at a significant distance (∼36 Å) from HL and S1D, the region where the original mutation resides, suggesting potential allosteric mechanisms, rather than a simple reversal of original mutation, may operate in the suppression.

Following a 6 hr shift to 36°C, nearly 80% of *myo2*-E1 cells became multinucleate and had either improper septa with a wavy and patchy appearance or did not have a septum ([Figure 1](#fig1){ref-type="fig"}B). By contrast, only ∼35% of *myo2*-E1-Sup1 cells contained such defects, while those defects were rarely seen in wild-type cells ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}C). Since the ingressing actomyosin ring guides division septum assembly, we investigated the dynamics of the actomyosin ring component Rlc1p-3GFP in wild-type, *myo2*-E1, and *myo2*-E1-Sup1 strains; mCherry-tubulin served as a cell-cycle marker in these experiments. In wild-type cells, actomyosin rings were assembled in metaphase/anaphase A in ∼12.8 ± 0.6 min and contracted following spindle breakdown in ∼22 ± 1.9 min, with an intervening dwell phase of 5 ± 0.8 min during which the actomyosin ring was stably maintained ([Figures 1](#fig1){ref-type="fig"}C--1E and [S1](#mmc1){ref-type="supplementary-material"}D). As expected, all aspects of cytokinesis were slower in myo2-E1 mutants compared to wild-type cells: improper ring assembly took ∼38 ± 6.9 min and improper contraction/disassembly lasted ∼82 ± 16.2 min at 36°C ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}D). Imaging *myo2*-E1-Sup1 cells revealed that they assembled actomyosin rings of normal appearance ([Figure 1](#fig1){ref-type="fig"}C, time point 24 min, ending on views in [Figure S1](#mmc1){ref-type="supplementary-material"}D), with a significantly accelerated kinetics for both ring assembly (∼18.6 ± 1.5 min) and contraction (∼34.2 ± 3 min) compared to the original *myo2*-E1 mutant. Nevertheless, both steps were marginally slower in *myo2*-E1-Sup1 compared to wild-type cells ([Figures 1](#fig1){ref-type="fig"}C--1E and [S1](#mmc1){ref-type="supplementary-material"}D). Whereas actomyosin rings in wild-type cells contracted at ∼0.6 ± 0.1 μm/min, contraction rate in *myo2*-E1-Sup1 cells was ∼0.4 ± 0.08 μm/min at 36°C. These experiments established that *myo2*-E1-Sup1 assembled contractile rings of normal appearance, although both ring assembly and ring contraction took ∼1.5 times longer compared to wild-type cells.

Two type II myosin heavy chains participate in cytokinesis in *S. pombe* \[[@bib14], [@bib15], [@bib16], [@bib17]\]. We therefore investigated the possibility that Myp2p, which is normally non-essential for ring assembly, assisted in actomyosin ring assembly and contraction in the *myo2*-E1-Sup1 strain through a potential ectopic upregulation. Toward this goal, we generated a double mutant of the genotype *myo2*-E1-Sup1 myp2Δ. Although this strain was viable at 24°C, surprisingly, it was inviable at 36°C ([Figure 2](#fig2){ref-type="fig"}A). Time-lapse microscopy was performed on wild-type, *myo2*-E1 *myp2*Δ, *myo2*-E1-Sup1 *myp2*Δ, and *myp2*Δ strains to investigate aspects of actomyosin ring function. The time taken for ring assembly and contraction and the ring contraction rate were comparable in wild-type and *myp2*Δ cells ([Figures 2](#fig2){ref-type="fig"}B--2F), clarifying that Myp2p is not important for either ring assembly or contraction at 36°C when Myo2p is fully functional. *myo2*-E1 *myp2*Δ assembled abnormal actomyosin rings that underwent abnormal disassembly ([Figures 2](#fig2){ref-type="fig"}B and 2C). *myo2*-E1-Sup1 *myp2*Δ assembled actomyosin rings of normal appearance, and the assembly of these rings took ∼6 min more than wild-type and *myp2*Δ cells ([Figures 2](#fig2){ref-type="fig"}B--2D). Ring contraction was dramatically affected in *myo2*-E1-Sup1 *myp2*Δ ([Figures 2](#fig2){ref-type="fig"}B, 2C, 2E, and 2F). Contraction and disassembly took more than twice the amount of time compared to wild-type cells, while the ring contraction rate was less than half of that observed in wild-type cells ([Figures 2](#fig2){ref-type="fig"}E and 2F). Furthermore, contraction was frequently asymmetric and led to rings disassembling abnormally and often to the fragmentation of the ring into two or more clusters ([Figures 2](#fig2){ref-type="fig"}B, time points 48--72 min, and [2](#fig2){ref-type="fig"}C). Since *myo2*-E1-Sup1 *myp2*Δ and *myo2*-E1-Sup1 were capable of actomyosin ring assembly but showed appreciable defects in ring contraction, we conclude Myo2p activity is essential for ring assembly and contraction, whereas Myp2p plays an ancillary role in promoting inefficient contraction when Myo2p motor activity is compromised at 36°C (compare ring contraction times and rates between *myo2*-E1-Sup1 and *myo2*-E1-Sup1 *myp2*Δ in [Figures 2](#fig2){ref-type="fig"}E and 2F).

Analysis of three-dimensional structures of rigor myosin (actin bound: 4A7F) and blebbistatin-bound myosin (actin unbound: 1YV3) suggested that the amino acid substitutions in *myo2*-E1-Sup1 may result in increased binding affinity toward F-actin ([Figure S2](#mmc1){ref-type="supplementary-material"}; see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for a detailed description of the structural analysis). This in turn may lead to defective actomyosin ring contraction due to *myo2*-E1-Sup1 being tightly bound to actin, leading to an actin filament translocation defect.

We have already developed methods to isolate ATP-dependent contraction-competent actomyosin rings \[[@bib8], [@bib18]\]. We therefore used this system to test if isolated actomyosin rings in cell ghosts from *myo2*-E1-Sup1 were capable of ATP-dependent contraction. Actomyosin rings were isolated from wild-type, *myo2*-E1, *myp2*Δ, *myo2*-E1 *myp2*Δ, *myo2*-E1-Sup1, and *myo2*-E1-Sup1 *myp2*Δ cells grown at the permissive temperature of 24°C. Actomyosin rings isolated from wild-type and myp2Δ cells underwent normal and rapid contraction upon ATP addition ([Figures 3](#fig3){ref-type="fig"}A and 3B). As previously reported \[[@bib8]\], upon the addition of 0.5 mM ATP, actomyosin rings isolated from *myo2*-E1 and *myo2*-E1 myp2Δ either contracted slowly or underwent fragmentation ([Figures 3](#fig3){ref-type="fig"}A and 3B). Interestingly, despite the moderate delay in ring assembly timing, actomyosin rings of normal appearance assembled in *myo2*-E1-Sup1 and *myo2*-E1-Sup1 *myp2*Δ at the restrictive temperature. However, rings isolated from these strains did not contract normally, even at the permissive temperature for *myo2*-E1 (24°C). Instead, rings from these strains remained stable and broke into large fragments. These experiments established that, consistent with in vivo results, rings isolated from *myo2*-E1-Sup1 and *myo2*-E1-Sup1 *myp2*Δ cells are defective in ATP-dependent contraction in vitro. These results were consistent with the idea that the product of *myo2*-E1-Sup1 is defective in its motor activity and actin filament translocation, but not in actin filament binding, which in turn may explain the ability of *myo2*-E1-Sup1 to support actomyosin ring assembly, but not contraction. However, it was possible that the actin translocation defect in *myo2*-E1-Sup1 was due to allosteric effects on other unidentified components of the actomyosin ring that affect ring contraction, rather than a direct effect of *myo2*-E1-Sup1 on actin filament translocation.

To distinguish between these possibilities, we purified the products of *myo2*^+^, *myo2*-E1, and *myo2*-E1-Sup1 using an expression system developed by Lord and Pollard \[[@bib11]\]. *Myo2*-E1-Sup1p was more difficult to purify (potentially due to its tight binding to actin) and was eventually isolated from Latrunculin A-treated cells ([Figure S3](#mmc1){ref-type="supplementary-material"}A). We then performed actin motility assays as described in Lord and Pollard \[[@bib11]\]. In brief, Myo2p and the mutant versions were immobilized on nitrocellulose-coated coverslips, overlaid with rhodamine-phalloidin-stabilized rabbit actin filaments, and incubated with ATP ([Figures 4](#fig4){ref-type="fig"}A, 4B, [S3](#mmc1){ref-type="supplementary-material"}B, and S3C; [Movies S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, and [S4](#mmc5){ref-type="supplementary-material"}). We found that wild-type Myo2p was able to bind and translocate actin filaments at ∼0.72 ± 0.13 μm/s when incubated with ATP. Also, as previously reported \[[@bib11]\], Myo2-E1p did not attach to actin filaments ([Movie S2](#mmc3){ref-type="supplementary-material"}). Interestingly, unlike the product of *myo2*-E1, the product of *myo2*-E1-Sup1 bound actin tightly, since these filaments were either severely affected for motility or were non-motile (gliding velocity was ∼0.06 ± 0.04 μm/s). Myo2-E1-Sup1p also had a dominant effect when mixed with wild-type Myo2p. The mixture bound to actin filaments but these filaments were non-motile. The fact that Myo2-E1-Sup1p did not support motility, despite binding actin filaments and its dominant-negative effect on motility over wild-type Myo2p, suggests that Myo2-E1-Sup1p is most likely a novel rigor mutant of Myo2p.

Our work reported in this study establishes that the type II myosin, Myo2p, plays two distinct and essential roles. Since cells harboring the novel rigor mutant allele *myo2*-E1-Sup1 assemble normal actomyosin rings, despite the defective contraction in vitro and in vivo, it is possible that actomyosin ring assembly depends on the ability of Myo2p to cross-link actin filaments. Actomyosin ring assembly in *myo2*-E1-Sup1 cells is slower than in wild-type cells (possibly due to cross-linking and tighter binding of Myo2-E1-Sup1p with actin), suggesting that myosin II motor activity may also play a role in actomyosin ring assembly, as previously proposed \[[@bib19], [@bib20]\]. It is possible that clustering of cytokinetic precursor nodes can occur through tension generated by myosin II-dependent cross-linking of actin filaments. This view is consistent with aspects of the work of Ma and colleagues who have proposed that actin translocation activity of myosin II is not essential for cytokinesis \[[@bib4]\]. Inconsistent with the work of Ma and colleagues, however, are our findings that actomyosin rings in *myo2*-E1-Sup1 cells do not contract normally, that actomyosin rings isolated from those cells fail to undergo ATP-dependent contraction, and that one-step-purified Myo2-E1-Sup1p does not support ATP-dependent actin filament motility in vitro. These observations suggest that myosin II motor activity is essential for actomyosin ring contraction.

Thus, through the analysis of novel myosin II mutant alleles, we have been able to discriminate between myosin II motor activity-dependent and -independent steps in cytokinesis. Published work in *S. cerevisiae* and mammalian cells \[[@bib4], [@bib5], [@bib21]\] has questioned the role of myosin II motor activity in cytokinesis. It is likely that in some cell types, tension generated by actin filament cross-linking and filament disassembly alone may suffice for cytokinesis, whereas in others such as *S. pombe*, cytokinesis may depend on motor activity-dependent and -independent functions of myosin II.
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![*myo2*-E1-Sup1 Restores Actomyosin Ring Assembly and Partial Ring Contraction\
(A) Serial dilutions (10-fold) of wild-type, *myo2*-E1, and the intragenic suppressor *myo2*-E1-Sup1 were spotted onto yeast extract agar (YEA) plates and grown for 3 days at 24°C and 36°C.\
(B) Quantification of DAPI and anillin blue staining used to visualize the nucleus and septum of wild-type, *myo2*-E1, and *myo2*-E1-Sup1 cells, respectively. Phenotypes of the mutants were categorized into two types: septa with two nuclei (S/2N) and cells with abnormal cytokinesis, revealed by the presence of multiple septa and nuclei (MS/\>2N).\
(C) Time-lapse series of wild-type, *myo2*-E1, and *myo2*-E1-Sup1 cells expressing 3GFP-tagged myosin regulatory light chain (Rlc1-3GFP) as a contractile ring marker and mCherry-tagged tubulin (mCherry-atb2) as a cell-cycle stage marker. Cells were grown at 24°C and shifted to 36°C for 3--4 hr before imaging at 36°C (t = 0 indicates the time before Rlc1-3GFP nodes localize to the cell middle). Images shown are maximum-intensity projections of z stacks. Scale bars represent 3 μm.\
(D) Timing of contractile ring assembly, maturation/dwelling, and contraction. Quantification of (C) is shown. Error bars represent SD.\
(E) Timing of actomyosin ring assembly from nodes. Quantification of (C) is shown (asterisks indicate the statistical significance of the difference between the two genotypes). Statistical significance was calculated by Student's t test (^∗∗∗∗^p \< 0.0001). Error bars represent SD.\
(F) Timing of actomyosin ring contraction. Quantification of (C) is shown. Statistical significance was calculated by Student's t test (^∗∗∗∗^p \< 0.0001). Error bars represent SD.\
(G) Constriction rate determined from a graph of ring circumference versus time. Statistical significance was calculated by Student's t test (^∗∗∗∗^p \< 0.0001). Error bars represent SD.\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![*myo2*-E1-Sup1 Fails in Actomyosin Ring Contraction in the Absence of the Non-essential Myosin Heavy Chain Myp2p\
(A) Serial dilutions (10-fold) of wild-type, *myo2*-E1, *myp2*Δ, *myo2*-E1 *myp2*Δ, and *myo2*-E1-Sup1 *myp2*Δ were spotted onto YEA plates and grown for 3 days at 24°C and 36°C.\
(B) Time-lapse series of wild-type, *myp2*Δ, *myo2*-E1 *myp2*Δ, and *myo2*-E1-Sup1 *myp2*Δ cells expressing 3GFP-tagged myosin regulatory light chain (Rlc1-3GFP) as a contractile ring marker and mCherry-tagged tubulin (atb2-mCherry) as a cell-cycle stage marker. Cells were grown at 24°C and shifted to 36°C for 3--4 hr before imaging at 36°C (t = 0 indicates the time before Rlc1-3GFP nodes localize to the cell middle). Images shown are maximum-intensity projections of z stacks. Scale bars represent 3 μm.\
(C) Kymographs of a 3D-projected ring from wild-type, *myo2*-E1 *myp2*Δ, and *myo2*-E1-Sup1 *myp2*Δ cells. Scale bars represent 3 μm.\
(D) Timing of actomyosin ring assembly from nodes. Quantification of (B) is shown. Asterisks indicate the statistical significance of the difference between the different genotypes compared to the wild-type. Statistical significance was calculated by Student's t test (^∗∗∗∗^p \< 0.0001). Error bars represent SD.\
(E) Timing of actomyosin ring contraction. Quantification of [Figure 1](#fig1){ref-type="fig"}C and (B) is shown. Statistical significance was calculated by Student's t test (^∗∗∗∗^p \< 0.0001). Error bars represent SD.\
(F) Constriction rate determined from a graph of ring circumference versus time. Contraction rates of [Figure 1](#fig1){ref-type="fig"}C and (B) are shown. Statistical significance was calculated by Student's t test (^∗∗∗∗^p \< 0.0001). Error bars represent SD.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Isolated Actomyosin Rings of *myo2*-E1-Sup1 Do Not Undergo ATP-Dependent Contraction\
(A) Cell ghosts were prepared from wild-type, *myo2*-E1, *myp2Δ, myo2*-E1 *myp2Δ*, *myo2*-E1-Sup1, and *myo2*-E1-Sup1 *myp2*Δ grown at 24°C. Ring contraction experiments were performed at 24°C and contraction was activated by the addition of 0.5 mM ATP. Images shown are maximum-intensity projections of z stacks. Scale bars represent 5 μm.\
(B) Graph showing percentage of contracted, clustered, and broken rings. Quantification of (A) is shown.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Myo2-E1-Sup1p Showed Tighter Actin Binding but No Motility\
(A) Type II Myosin-based actin filament-gliding assay. Representative kymographs of time-lapse fluorescence micrographs of actin filaments labeled with rhodamine-phalloidin are shown. Scale bars represent 5 μm.\
(B) Quantification of the actin filament-gliding assay of (A). Different myosins (Myo2p, Myo2-E1-Sup1p, and Myo2p + Myo2-E1-Sup1p) were tested for gliding velocity (μm/s) using rhodamine-phalloidin-labeled actin.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Movies S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, and [S4](#mmc5){ref-type="supplementary-material"}.](gr4){#fig4}
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